Subscribe To Our Free Newsletter |
Torrent Pharma’s Indrad facility gets Form 483 with 5 observations from US FDA
Torrent Pharmaceuticals said that the company's Gujarat-based manufacturing facility received Form 483 with five observations from the United States Food and Drug Administration (US FDA).